Paloma Partners Management CO Jounce Therapeutics, Inc. Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$3.43 - $6.87 $60,025 - $120,225	-17,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.69 - $6.71 $47,075 - $117,425	17,500 New	17,500 $59,000
Q2 2018 Aug 14, 2018	SELL	$7.27 - $21.88 $121,459 - $365,549	-16,707 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.4 - $28.4 $17,420 - $36,920	-1,300 Reduced 7.22%	16,707 $373,000
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $225,447 - $320,884	18,007	18,007 $230,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.